Pay in 4 interest-free payments of $7.31 Learn more
Ships within 48 hours · Estimated delivery Aug 8 - Aug 13
Glycemic durability of rosiglitazone, metformin, or glyburide monotherapy
found that GLP-1 RAs are associated with an increased risk of gallbladder and biliary diseases (including cholelithiasis and cholecystitis), particularly at higher doses, longer treatment durations, and when used for weight loss [129]
PMID: 264 WojtowiczKSterzyskaKwierczewskaMNowickiMZabelMJanuchowskiR
This study will examine the safety and efficacy of TNX-102 SL to reduce ASR symptoms and behavioral changes among patients presenting to the emergency
W.LiL.MelchiorsenJ
Development of peptide therapeutics: A nonclinical safety assessment perspective
US$ 23.78
US$ 28.29
US$ 21.02
US$ 25.36
US$ 29.29
US$ 25.09
US$ 27.61
